Related references
Note: Only part of the references are listed.Swimming into the Future of Drug Discovery: In Vivo Chemical Screens in Zebrafish
Teresa V. Bowman et al.
ACS CHEMICAL BIOLOGY (2010)
Typical and atypical antipsychotics alter acetylcholinesterase activity and ache expression in zebrafish (Danio rerio) brain
Kelly Juliana Seibt et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY (2009)
The use of in vivo zebrafish assays in drug toxicity screening
Peter M. Eimon et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery
T. P. Barros et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Schizophrenia and sudden cardiac death - A review
Hannu Koponen et al.
NORDIC JOURNAL OF PSYCHIATRY (2008)
Zebrafish based assays for the assessment of cardiac, visual and gut function — potential safety screens for early drug discovery
Stéphane Berghmans et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2008)
Evaluation of zebrafish embryos as a model for assessing inhibition of hERG
S.W. Mittelstadt et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2007)
Zebrafish as a model for developmental neurotoxicity testing
Christopher Ton et al.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2006)
In vivo drug discovery in the zebrafish
LI Zon et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Drugs that induce repolarization abnormalities cause bradycardia in zebrafish
DJ Milan et al.
CIRCULATION (2003)
Share Paper
